No Data
No Data
Bairen Healthcare Third Quarter Report 2024
beijing balance medical technology co., ltd. (688198.SH): The net income in the first three quarters was 58.6934 million yuan, a year-on-year decrease of 16.56%.
On October 29, beijing balance medical technology co., ltd. (688198.SH) announced that in the first three quarters of 2024, it achieved a total operating income of 0.292 billion yuan, a year-on-year increase of 13.57%; the net income attributable to shareholders of the parent company decreased by 16.56% to 58.6934 million yuan; the basic earnings per share was 0.43 yuan.
Has the source of funds for the controlling shareholder's shareholding changed? Beijing Balance Medical Technology Co., Ltd. insider: Self-financing can also be done through "special shareholding loans".
①Company insiders have expressed that beijing balance medical technology co., ltd. plans to increase its shareholding through self-raised funds, not ruling out the possibility of increasing company stocks through bank's "stock shareholding special loans". ②Jin Lei, the director of beijing balance medical technology co., ltd., believes that against the backdrop of a sluggish performance in the medical instruments sector, the company's stock price is undervalued by the market.
The first case! The controlling shareholder of a listed company intends to increase shareholding by borrowing money. The latest response from beijing balance medical technology co., ltd. has arrived.
① Economist Song Qinghui stated that the interest rates of special loans are relatively low, but if a listed company fails to repay the debt within the specified time, they may face higher financing costs and financial pressure. ② Jin Lei believes that beijing balance medical technology co., ltd. has entered a stage of steady development. As a major shareholder of the company, the annual shareholder dividends can fully cover loan interest, avoiding financial risks caused by loans from banks.
The first shot of the 300 billion refinancing entering the market! Beijing Balance Medical Technology Co., Ltd.'s actual controller intends to increase shareholding with special loans.
The central bank's share buyback and shareholding again loan policy have attracted people who are willing to take the lead. Beijing Balance Medical Technology Co., Ltd.'s shareholder and actual controller, Jin Lei, plans to use special loan funds to increase the company's shares by no less than 0.1 million shares; Market participants believe that the medical instruments industry has been declining in the capital markets for several years in a row, which is not in line with the gradually improving fundamentals, perhaps because the re-lending buyback is the first to land in this industry.
Summary of Beijing Balance Medical Technology Co., Ltd.'s 2024 semi-annual report
No Data
No Data